Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans and moderate activity against Neisseria gonorrhoeae.
Sample possesses significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans and moderate activity against Neisseria gonorrhoeae.
Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans, and moderate activity against Neisseria gonorrhoeae.
Sample presents significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Streptococcus agalactiae and Cryptococcus neoformans.
Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Streptococcus agalactiae and Cryptococcus neoformans.
Sample possesses significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Neisseria gonorrhoeae, Streptococcus agalactiae, and Cryptococcus neoformans.
Cryptococcus neoformansCryptococcosis caused by C. neoformans is a very serious disease, with a mortality rate ranging from 41% to 61%, particularly in patients with HIV infection.